Else Nutrition
100% vegan baby formula and infant and toddler nutrition.
Launch date
Employees
Market cap
AUD6.7m
Enterprise valuation
AUD9m (Public information from Sep 2024)
Share price
CAD0.03 BABY.TO
Tel Aviv-Yafo Tel Aviv District (HQ)
Financials
Estimates*
| CAD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | 8.5m | <1m | 1.5m | 4.7m | 8.5m | 9.4m | 27.4m |
| % growth | - | (94 %) | 168 % | 216 % | 82 % | 10 % | 193 % |
| EBITDA | (<1m) | (<1m) | 6.3m | (33.4m) | (23.0m) | (19.1m) | (13.0m) |
| % EBITDA margin | (2 %) | (102 %) | 423 % | (713 %) | (269 %) | (204 %) | (47 %) |
| Profit | (<1m) | (5.4m) | (24.1m) | (1.6m) | (17.6m) | (15.6m) | - |
| % profit margin | (2 %) | (971 %) | (1626 %) | (35 %) | (207 %) | (167 %) | - |
| EV / revenue | - | 59.2x | 233.1x | 20.4x | 5.8x | 3.0x | 1.1x |
| EV / EBITDA | - | -58.1x | 55.2x | -2.9x | -2.2x | -1.4x | -2.2x |
| R&D budget | - | <1m | 1.1m | 2.0m | 2.6m | 2.6m | - |
| R&D % of revenue | - | 47 % | 75 % | 42 % | 30 % | 27 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| N/A | CAD7.5m | Post IPO Equity | |
$8.0m | Post IPO Equity | ||
CAD25.7m | Post IPO Equity | ||
* | N/A | $17.3m | Post IPO Equity |
* | $4.1m | Post IPO Equity | |
* | $2.4m | Post IPO Convertible | |
* | N/A | CAD5.0m | Post IPO Equity |
* | $1.0m | Post IPO Convertible | |
| Total Funding | - | ||
Related Content
Recent News about Else Nutrition
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.